| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2020-11-23 19:39:23 UTC |
|---|
| Updated at | 2025-02-11 15:43:38 UTC |
|---|
| NP-MRD ID | NP0002746 |
|---|
| Natural Product DOI | https://doi.org/10.57994/1440 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Maleamic acid |
|---|
| Provided By | BMRB |
|---|
| Description | Maleamate, also known as maleamic acid or maleic monoamide, belongs to the class of organic compounds known as straight chain fatty acids. These are fatty acids with a straight aliphatic chain. Maleamic acid is found in Pogostemon cablin and Trypanosoma brucei. Maleamic acid was first documented in 2000 (PMID: 10742217). Based on a literature review a small amount of articles have been published on Maleamate (PMID: 22530095) (PMID: 31433182) (PMID: 30646534). |
|---|
| Structure | [H]\C(=C(/[H])C(O)=O)C(O)=N InChI=1S/C4H5NO3/c5-3(6)1-2-4(7)8/h1-2H,(H2,5,6)(H,7,8)/b2-1- |
|---|
| Synonyms | | Value | Source |
|---|
| (Z)-3-Carbamoyl acrylic acid | ChEBI | | (Z)-4-Amino-4-oxo-2-butenoic acid | ChEBI | | Maleic monoamide | ChEBI | | Maleamic acid | Kegg | | (Z)-3-Carbamoyl acrylate | Generator | | (Z)-4-Amino-4-oxo-2-butenoate | Generator | | Maleamate | Generator | | Maleic acid monoamide | MeSH |
|
|---|
| Chemical Formula | C4H5NO3 |
|---|
| Average Mass | 115.0874 Da |
|---|
| Monoisotopic Mass | 115.02694 Da |
|---|
| IUPAC Name | (2Z)-3-(C-hydroxycarbonimidoyl)prop-2-enoic acid |
|---|
| Traditional Name | maleic monoamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H]\C(=C(/[H])C(O)=O)C(O)=N |
|---|
| InChI Identifier | InChI=1S/C4H5NO3/c5-3(6)1-2-4(7)8/h1-2H,(H2,5,6)(H,7,8)/b2-1- |
|---|
| InChI Key | FSQQTNAZHBEJLS-UPHRSURJSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| HSQC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum | | HMBC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum | | COSY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| | Chemical Shift Submissions |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600.133705802, CD3OD, simulated) | bgnzk@missouri.edu | Sumner Lab, MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum |
| | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as straight chain fatty acids. These are fatty acids with a straight aliphatic chain. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Fatty acids and conjugates |
|---|
| Direct Parent | Straight chain fatty acids |
|---|
| Alternative Parents | Not Available |
|---|
| Substituents | Not Available |
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - McLaggan D, Rufino H, Jaspars M, Booth IR: Glutathione-dependent conversion of N-ethylmaleimide to the maleamic acid by Escherichia coli: an intracellular detoxification process. Appl Environ Microbiol. 2000 Apr;66(4):1393-9. doi: 10.1128/AEM.66.4.1393-1399.2000. [PubMed:10742217 ]
- Tang H, Yao Y, Wang L, Yu H, Ren Y, Wu G, Xu P: Genomic analysis of Pseudomonas putida: genes in a genome island are crucial for nicotine degradation. Sci Rep. 2012;2:377. doi: 10.1038/srep00377. Epub 2012 Apr 23. [PubMed:22530095 ]
- Ion BF, Meister PJ, Gauld JW: Multiscale Computational Study on the Catalytic Mechanism of the Nonmetallo Amidase Maleamate Amidohydrolase (NicF). J Phys Chem A. 2019 Sep 12;123(36):7710-7719. doi: 10.1021/acs.jpca.9b05914. Epub 2019 Sep 3. [PubMed:31433182 ]
- Diaz-Garcia D, Ardiles PR, Prashar S, Rodriguez-Dieguez A, Paez PL, Gomez-Ruiz S: Preparation and Study of the Antibacterial Applications and Oxidative Stress Induction of Copper Maleamate-Functionalized Mesoporous Silica Nanoparticles. Pharmaceutics. 2019 Jan 14;11(1). pii: pharmaceutics11010030. doi: 10.3390/pharmaceutics11010030. [PubMed:30646534 ]
|
|---|